Lynne Marie Sullivan

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ by Kimberly Cornwell as attorney-in-fact for Lynne Marie Sullivan
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Lynne Marie Sullivan

Form 4 holding CFO & Head of Corp. Dev.

Unity Biotechnology, Inc.

Security class
Common Stock, $0.0001 par value
Shares / value
98,905
Estimated value
$101,872
Report date
02 Apr 2025
Price
$1.03
Ownership
Direct
Form 4 holding CFO & Head of Corp. Dev.

Unity Biotechnology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
106,000
Estimated value
Report date
28 Mar 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Solid Biosciences Inc.

Security class
Director Stock Option (Right to Buy)
Shares / value
77,500
Estimated value
Report date
10 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

BiomX Inc.

Security class
Common Stock Options - Right to Buy
Shares / value
41,000
Estimated value
Report date
01 Mar 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Inozyme Pharma, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
01 Jul 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Lynne Marie Sullivan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .